Følg
Martin Schäfer
Martin Schäfer
Professor of Psychiatry, Kliniken Essen-Mitte, Charité-Universitätsmedizin Berlin
Bekræftet mail på kem-med.com
Titel
Citeret af
Citeret af
År
Adherence and mental side effects during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groups
M Schaefer, F Schmidt, C Folwaczny, R Lorenz, G Martin, N Schindlbeck, ...
Hepatology 37 (2), 443-451, 2003
4602003
Interferon alpha (IFNα) and psychiatric syndromes: a review
M Schaefer, MA Engelbrechta, O Gut, BL Fiebich, J Bauer, F Schmidt, ...
Progress in Neuro-Psychopharmacology and Biological Psychiatry 26 (4), 731-746, 2002
2752002
Hepatitis C infection, antiviral treatment and mental health: a European expert consensus statement
M Schaefer, L Capuron, A Friebe, C Diez-Quevedo, G Robaeys, S Neri, ...
Journal of hepatology 57 (6), 1379-1390, 2012
2612012
Prevention of interferon-alpha associated depression in psychiatric risk patients with chronic hepatitis C
M Schaefer, M Schwaiger, AS Garkisch, M Pich, A Hinzpeter, ...
Journal of hepatology 42 (6), 793-798, 2005
2302005
Association of short-term response to haloperidol treatment with a polymorphism in the dopamine D2 receptor gene
M Schäfer, D Rujescu, I Giegling, A Guntermann, A Erfurth, B Bondy, ...
American Journal of Psychiatry 158 (5), 802-804, 2001
1972001
Recommendations for the management of hepatitis C virus infection among people who inject drugs
J Grebely, G Robaeys, P Bruggmann, A Aghemo, M Backmund, ...
International Journal of Drug Policy 26 (10), 1028-1038, 2015
1952015
Reduction of physiological stress by urban green space in a multisensory virtual experiment
M Hedblom, B Gunnarsson, B Iravani, I Knez, M Schaefer, P Thorsson, ...
Scientific reports 9 (1), 10113, 2019
1922019
Hepatitis C treatment in “difficult‐to‐treat” psychiatric patients with pegylated interferon‐alpha and ribavirin: response and psychiatric side effects
M Schaefer, A Hinzpeter, A Mohmand, G Janssen, M Pich, M Schwaiger, ...
Hepatology 46 (4), 991-998, 2007
1892007
Treatment of chronic hepatitis C in patients with drug dependence: time to change the rules?
M Schaefer, A Heinz, M Backmund
Addiction 99 (9), 1167-1175, 2004
1682004
Recommendations for the management of hepatitis C virus infection among people who inject drugs
G Robaeys, J Grebely, S Mauss, P Bruggmann, J Moussalli, A De Gottardi, ...
Clinical Infectious Diseases 57 (suppl_2), S129-S137, 2013
1342013
Bipartite interactions, antibiotic production and biosynthetic potential of the Arabidopsis leaf microbiome
EJN Helfrich, CM Vogel, R Ueoka, M Schäfer, F Ryffel, DB Müller, ...
Nature Microbiology 3 (8), 909-919, 2018
1202018
Feasibility and outcome of substitution treatment of heroin-dependent patients in specialized substitution centers and primary care facilities in Germany: a naturalistic study …
HU Wittchen, SM Apelt, M Soyka, M Gastpar, M Backmund, J Gölz, ...
Drug and alcohol dependence 95 (3), 245-257, 2008
1202008
Cognitive impairment in patients with chronic hepatitis treated with interferon alpha (IFNα): results from a prospective study
K Lieb, MA Engelbrecht, O Gut, BL Fiebich, J Bauer, G Janssen, ...
European psychiatry 21 (3), 204-210, 2006
1102006
Antimanic efficacy of topiramate in 11 patients in an open trial with an on-off-on design
HCR Grunze, C Normann, J Langosch, M Schaefer, B Amann, A Sterr, ...
Journal of Clinical Psychiatry 62 (6), 464-468, 2001
1002001
Neurotransmitter changes by interferon-alpha and therapeutic implications
M Schaefer, M Schwaiger, M Pich, K Lieb, A Heinz
Pharmacopsychiatry 36 (S 3), 203-206, 2003
962003
Neurobiological correlates of the disposition and maintenance of alcoholism
A Heinz, M Schäfer, JD Higley, JH Krystal, D Goldman
Pharmacopsychiatry 36 (S 3), 255-258, 2003
912003
Escitalopram for the prevention of peginterferon-α2a–associated depression in hepatitis C virus–infected patients without previous psychiatric disease: a randomized trial
M Schaefer, R Sarkar, V Knop, S Effenberger, A Friebe, L Heinze, ...
Annals of Internal Medicine 157 (2), 94-103, 2012
872012
Acute antimanic efficacy and safety of oxcarbazepine in an open trial with an on‐off‐on design
B Hummel, J Walden, R Stampfer, S Dittmann, B Amann, A Sterr, ...
Bipolar disorders 4 (6), 412-417, 2002
852002
Correlation between sICAM-1 and depressive symptoms during adjuvant treatment of melanoma with interferon-α
M Schaefer, M Horn, F Schmidt, MH Schmid-Wendtner, M Volkenandt, ...
Brain, Behavior, and Immunity 18 (6), 555-562, 2004
772004
Animal behaviour: evolution and mechanisms
N Anthes, R Bergmüller, W Blanckenhorn, HJ Brockmann, C Fichtel, ...
Springer Science & Business Media, 2010
762010
Systemet kan ikke foretage handlingen nu. Prøv igen senere.
Artikler 1–20